SCHEMBL8224744

SCHEMBL8224744

Cn1ccc2nc(O)c(-c3cccs3)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 4/20 0.45
ALDH1A1 P00352 8/20 0.42
CYP1A2 P05177 7/20 0.42
CASP1 P29466 7/20 0.42
CASP7 P55210 7/20 0.42
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
USP2 O75604 6/20 0.42
CYP3A4 P08684 6/20 0.42
HIF1A Q16665 6/20 0.42
CYP2C9 P11712 6/20 0.42
HSD17B10 Q99714 6/20 0.42
CLK4 Q9HAZ1 3/20 0.42
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15958616 0.81 RPS6KB2 (0.47) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL8226859 0.78 RPS6KB2 (0.50) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL7907933 0.78 ALDH1A1 (0.39) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL8380330 0.78 CYP1A2 (0.41) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL7907910 0.75 CYP1A2 (0.41) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL8380552 0.75 CYP1A2 (0.44) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL31265460 0.75 RPS6KB2 (0.61) RPS6KB2ALDH1A1CASP1CASP7MEN1
SCHEMBL578071 0.75 RPS6KB2 (0.61) RPS6KB2ALDH1A1CASP1CASP7MEN1
SCHEMBL8230198 0.71 RPS6KB2 (0.51) RPS6KB2ALDH1A1CASP1CASP7MEN1
SCHEMBL20673873 0.70 KDM4E (0.33) CYP2C9KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008002924-A2 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-01-03 WO disclosed